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Abstract
Background: Although brain arteriovenous malformations (AVM) usually remain asymptomatic during pregnancy,
they can cause intracranial hemorrhage and lead to serious neurological deficits. Nowadays, it is accepted that
treatment of a ruptured brain AVM during pregnancy should be based on neurologic, not obstetric, indications.
Recently, endovascular treatment has been recognized as a treatment option associated in pregnant patients with
brain AVMs.
Case presentation: A 34-year-old woman presented at 25 weeks of gestation with a history of severe headache
followed by severe consciousness disturbance. Brain CT showed a subcortical hematoma in the right occipital lobe
along with bilateral intraventricular hematomas. A cerebral angiogram was performed to confirm the diagnosis,
which revealed right occipital AVM. At 27 weeks of gestation, endovascular embolization of the AVM was
attempted under general anesthesia. The feeding artery and the nidus were simultaneously obliterated by injection
of 50 % n-butyl-cyanoacrylate. As a result, the blood flow into the nidus was drastically decreased and the risk of
re-bleeding was substantially reduced. At 38 weeks of gestation, elective cesarean section was performed to deliver
the baby under combined spinal-epidural anesthesia (CSEA). An infant weighing 3665 g was delivered, with Apgar
scores of 8 and 9 at 1 and 5 min, respectively.
Postoperative analgesia was provided by a continuous infusion of ropivacaine via the epidural catheter. The infant
was confirmed as not having any congenital anomalies.
On POD 5, both of the patient and the infant were discharged home without any medical problems. The mother
has shown no evidence of re-bleeding from the intracranial lesion since, and the infant is thriving well.
Conclusions: Endovascular treatment in pregnant women is associated with various unique concerns. However, it
can be carried out safely and effectively and is useful not only for saving the mother’s life but also for allowing the
pregnancy to continue to term.
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Background
Although brain arteriovenous malformations (AVM)
usually remain asymptomatic during pregnancy, they
can cause intracranial hemorrhage and lead to serious
neurological deficits. It is widely accepted that treatment
of a ruptured brain AVM during pregnancy should be
based on neurologic, not obstetric, indications [1]. How-
ever, direct open surgery entails the risk of intraoperative
bleeding with deterioration of the uterine and placental
circulation and consequent risk also to the fetus [2]. Re-
cently, endovascular treatment, as a non-surgical ap-
proach, has been increasingly recognized as a treatment
option associated with a lower risk of re-bleeding in
pregnant patients with brain AVMs [2, 3]. Recent ad-
vances in the devices used in endovascular treatment in
conjunction with the development of various embolic
materials have encouraged this trend [2, 4].
We report a case of successful perinatal management
in a pregnant patient with a ruptured brain AVM by
endovascular embolization followed by elective cesarean
section. The patient recovered without any neurological
deficits, and the infant is thriving well.
Case presentation
A 34-year-old multipara woman, with a body weight of
66 kg and measuring 167 cm in height, presented to a
neighborhood hospital at 25 weeks of gestation with a
history of severe headache of sudden onset followed by
severe consciousness disturbance. On the arrival at the
hospital, she was assessed as E1V1M5 on the Glasgow
Coma Scale (GCS). Her vital signs were normal: blood
pressure (BP) 105/59 mmHg, heart rate (HR) 69 bpm,
and percutaneus oxygen saturation (SpO2) 100 % on
room air. Brain computed tomography (CT) showed a
subcortical hematoma in the right occipital lobe
along with bilateral intraventricular hematomas,
which were judged as being a result of rupture of a
brain AVM (Fig. 1). Fetal ultrasound revealed a fetus
matched for the gestational age, weighing 965 g.
Ventricular drainage was urgently performed to con-
trol the intracranial pressure and avoid obstructive
hydrocephalus.
On postoperative day (POD) 1, the patient’s conscious-
ness had fully recovered and she was assessed on the
GCS as E4VtM6. A cerebral angiogram was subse-
quently performed to confirm the diagnosis, which re-
vealed right occipital AVM; the feeding artery was single
and arose from the right posterior cerebral artery, feed-
ing a nidus measuring 1 cm in diameter. The draining
vein could not be clearly identified but likely drained
into the superior sagittal sinus (Spetzler and Martin
grade 2; size of the AVM, 1 point/eloquence of the adja-
cent brain, 1 point/pattern of venous drainage, 0 point)
(Fig. 2).
At 27 weeks of gestation, endovascular embolization
of the AVM was attempted under general anesthesia.
General anesthesia was induced with propofol 120 mg,
rocuronium 50 mg, and remifentanil 0.1 μg/kg/min and
maintained with end-tidal sevoflurane concentration
1.5 vol.% and remifentanil 0.05 μg/kg/min. The patient
was intubated with a 7.0-mm cuffed tube with no in-
crease of BP and HR and ventilated with 40 % oxygen to
maintain end-tidal carbon dioxide pressure between 30
and 34 mmHg. The patient’s abdomen was shielded to
minimize exposure of the fetus to radiation. The right
femoral artery was punctured, and a microcatheter was
advanced into a feeder of the AVM by flow control, not
directly into the nidus. The feeding artery and the nidus
were simultaneously obliterated by injection of 50 %
n-butyl-cyanoacrylate (NBCA) using live biplane road-
mapping systems. Although a tiny residual nidus con-
tinued to stain after the embolization, the procedure
was completed, because the blood flow into the nidus
was drastically decreased and the risk of re-bleeding
was substantially reduced.
The total amount of radiation exposure to the patient’s
head was determined to be 1446 mGy, with a fluoros-
copy time of 20 min 56 s. A total of 128 ml of iohexol,
as a non-ionic iodinated contrast agent, was adminis-
tered intravenously. After the embolization session and
Fig. 1 CT image showing a subcortical hematoma in the right
occipital lobe, along with bilateral intraventricular hematomas
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emergence of the patient from general anesthesia, a
complete neurological examination was performed to
assess the changes from the baseline, which con-
firmed the absence of any neurological deficit. We
also confirmed that the fetal HR (FHR) after the pro-
cedure was 140 bpm by Doppler monitor. Her intra-
cranial pressure was estimated to be below 15 cm
H2O by means of the intraventricular drainage tube.
On the 28th day from the rupture of the AVM, the
patient was discharged home without any neurological
problems. The patient went through the rest of her
pregnancy until fetal maturity without any obstetric
difficulties.
At 38 weeks of gestation, elective cesarean section was
performed to deliver the baby. Anesthesia was induced
by combined spinal-epidural anesthesia (CSEA). The
epidural catheter was atraumatically threaded at the
Th12-L1 epidural interspace, and puncture of the dura
at the L3-4 interspace was accomplished in the first at-
tempt. Hyperbaric 0.5 % bupivacaine 2.4 ml was injected
with fentanyl 15 mcg. An anesthetic level to T4 was ob-
tained after several minutes, and cesarean section was
performed uneventfully. An infant weighing 3665 g was
delivered, with Apgar scores of 8 and 9 at 1 and 5 min,
respectively. Postoperative analgesia was provided by a
continuous infusion of 0.2 % ropivacaine at 4 ml/h via
the epidural catheter. The infant was confirmed as not
having any congenital anomalies. On POD 5, both of the
patient and the infant were discharged home without
any medical problems.
One month after the delivery, CyberKnife radiosurgery
was performed in the patient as stereotactic irradiation
for the residual tiny AVM. The mother has shown no
evidence of re-bleeding from the intracranial lesion
since, and the infant is thriving well.
Discussion
Management of a ruptured brain AVM during preg-
nancy requires a multidisciplinary approach with close
cooperation among the neurosurgeon, obstetrician, and
anesthesiologist for the neurosurgical intervention and
the timing and mode of delivery. The risk of re-bleeding
in the same pregnancy has been reported to be about
27 %, associated with a 40 % higher mortality as com-
pared to that in age-matched non-gravid women [5, 6].
Therefore, the principle for goal of management of a
ruptured brain AVM is to minimize the risk of re-bleed-
ing until delivery. However, it is difficult to make the
optimal decisions for the treatment of coma-
producing brain AVMs, as there are no definitive
guidelines [7, 8].
Endovascular embolization has been used in increasing
frequency for the treatment of brain AVMs, not only as
radical treatment but also as treatment to decrease the
size of the nidus and reduce the blood flow to prevent
re-bleeding and facilitate subsequent surgical resection
or radiosurgery later [4, 9, 10].
According to the Food and Drug Administration
(FDA) recommendations, no drug is fundamentally safe
for pregnant women or fetuses. Especially, iodinated
contrast agents cross the human placenta and enter the
fetus. However, fetal hypothyroidism caused by intravas-
cular administration of non-ionic iodinated contrast
agents has not been reported so far [2]. In the present
patient, iohexol was used for the embolization, and no
abnormalities were observed in the infant. On the other
hand, it remains uncertain whether anesthetic agents
and adjuvants have an adverse effect on uteroplacental
unit and fetus in human [11]. Therefore, we consider
that the anesthesia for the AVM embolization should
have been managed with the use of FHR monitoring
Fig. 2 Vertebral angiogram, lateral view (left) and anteroposterior view (right), showing a grade 2 AVM. The brain AVM measured about 1 cm in
diameter (small, 1 point), was located adjacent to the visual cortex (eloquent, 1 point), and drained into the superior sagittal sinus (superficial
drainage only, 0 point)
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device such as cardiotocography (CTG) in case of non-
reassuring fetal status because some obstetric anesthesia
texts recommend FHR monitoring for the viable-age
fetus during non-obstetric surgery [11, 12].
Radiation exposure of the fetus is also a concern. The
International Commission on Radiological Protection
(ICRP) recommends that the maximum dose of radi-
ation to the uterus during pregnancy should be under
100 mGy to minimize the teratogenic risks to the fetus
[13]. Therefore, Le et al. suggested that delivering the
fetus prior to embolization of a brain AVM is preferable
to ensure minimal exposure of the fetus to radiation and
contrast agents [14]. On the other hand, Tanaka et al.
reported that the gonad was exposed to only 0.05–
0.07 mGy (0.01 % of the maximum radiation dose to the
head) when the head was exposed to a radiation dose of
800 mGy. The radiation dose to the gonad was thus far
below than 100 mGy limit recommended by the ICRP,
and the author concluded that the risk of radiation ex-
posure of the fetus associated with endovascular treat-
ment of brain AVMs is remarkably low [15]. According
to the Spetzler and Martin grading system, the AVM of
the present patient was judged as being grade 2 and as
being indicated for surgical resection [16]; however, it
was deep-seated in the brain and not located in an easily
accessible area (Fig. 2). Taking all these data into con-
sideration, it was considered that endovascular
embolization rather than resection would be beneficial
in the present patient. The radiation dose to the pa-
tient’s head was determined to be 1446 mGy, which
means that the exposure level of the uterus was
0.14 mGy at the maximum, which was less than the
recommended limit by the ICRP.
The anesthetic goal must be to provide strict
hemodynamic stability and stable intracranial pressure
(ICP) during cesarean section [14, 17]. Hypertension
should be avoided to decrease the risk of re-bleeding [8].
Although general anesthesia is described as acceptable
in pregnant patients with brain AVMs, hemodynamic in-
stability caused by endotracheal intubation, extubation,
and emesis is considered to be disadvantageous. In-
creased ICP associated with positive airway pressure
ventilation is also problematic. On the other hand, spinal
anesthesia would provide a sympathetic blockade and
allow a pregnant patient to remain awake during
cesarean section so that the anesthesiologist can monitor
the neurological functions. Although one of the most
common complications of spinal anesthesia, especially in
parturients, is the serious leakage of cerebrospinal fluid
(CSF) from the dura hole which results in decrease of
ICP, no previous cases of brain AVM re-bleeding by de-
crease of ICP induced by CSF drainage have been re-
ported in such patients. Epidural anesthesia is also
useful to provide postoperative analgesia in order to
avoid cardiovascular responses to pain and reduce the
risk of re-bleeding [17, 18].
Conclusions
Endovascular treatment in pregnant women is associated
with various unique concerns, such as the effects of radi-
ation and diagnostic/therapeutic agents on the fetus.
However, it can be carried out safely and effectively and
is useful not only for saving the mother’s life but also for
allowing the pregnancy to continue to term.
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